Article Details
Retrieved on: 2022-09-11 08:51:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The firm issued a sell rating on the biopharmaceutical company's stock. Separately, HC Wainwright reduced their target price on Minerva Neurosciences ...
Article found on: reporter.am
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here